Follow
Xiaowei Liu
Xiaowei Liu
West China Hospital, Sichuan University
Verified email at scu.edu.cn
Title
Cited by
Cited by
Year
Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice
L Li, L Song, X Liu, X Yang, X Li, T He, N Wang, S Yang, C Yu, T Yin, ...
ACS nano 11 (1), 95-111, 2017
2352017
Combination of immunotherapy with targeted therapy: theory and practice in metastatic melanoma
C Yu, X Liu, J Yang, M Zhang, H Jin, X Ma, H Shi
Frontiers in immunology 10, 431246, 2019
1162019
Immune checkpoint HLA-E: CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
X Liu, J Song, H Zhang, X Liu, F Zuo, Y Zhao, Y Zhao, X Yin, X Guo, X Wu, ...
Cancer Cell 41 (2), 272-287. e9, 2023
842023
Long non-coding RNAs: emerging roles in the immunosuppressive tumor microenvironment
Y Luo, J Yang, J Yu, X Liu, C Yu, J Hu, H Shi, X Ma
Frontiers in oncology 10, 48, 2020
642020
Novel antimicrobial peptide–modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus
X Liu, Z Li, X Wang, Y Chen, F Wu, K Men, T Xu, Y Luo, L Yang
International Journal of Nanomedicine, 6781-6794, 2016
582016
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
X He, X Liu, F Zuo, H Shi, J Jing
Seminars in Cancer Biology 88, 187-200, 2023
562023
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis
X Zheng, J Song, C Yu, Z Zhou, X Liu, J Yu, G Xu, J Yang, X He, X Bai, ...
Signal Transduction and Targeted Therapy 7 (1), 60, 2022
352022
MAPK‐Targeted drug delivered by a pH‐sensitive MSNP nanocarrier synergizes with PD‐1 blockade in melanoma without T‐cell suppression
X Liu, Y Feng, G Xu, Y Chen, Y Luo, J Song, Y Bao, J Yang, C Yu, Y Li, ...
Advanced Functional Materials 29 (12), 1806916, 2019
332019
Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
Y Zhao, X Liu, X Liu, J Yu, X Bai, X Wu, X Guo, Z Liu, X Liu
Frontiers in Immunology 13, 955920, 2022
292022
Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade
X Liu, Y Feng, J Xu, Y Shi, J Yang, R Zhang, J Song, X Bai, X Wu, Y Bao, ...
Journal of Controlled Release 332, 194-209, 2021
262021
Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
Y Luo, L Liu, Y Wu, K Singh, B Su, N Zhang, X Liu, Y Shen, S Huang
Oncotarget 6 (6), 4286, 2015
252015
Improvement of PD-1 blockade efficacy and elimination of immune-related gastrointestinal adverse effect by mTOR inhibitor
X Bai, X Wang, G Ma, J Song, X Liu, X Wu, Y Zhao, X Liu, Z Liu, W Zhang, ...
Frontiers in Immunology 12, 793831, 2021
172021
Application of photo-responsive metal-organic framework in cancer therapy and bioimaging
Y Zhao, X Jiang, X Liu, X Liu, Z Liu, X Liu
Frontiers in Bioengineering and Biotechnology 10, 1031986, 2022
122022
PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer
X Wang, J Yu, X Liu, D Luo, Y Li, L Song, X Jiang, X Yin, Y Wang, L Chai, ...
Cell Reports Medicine 3 (9), 2022
122022
A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment
X Liu, Y Zhao, X Wu, Z Liu, X Liu
Frontiers in Oncology 12, 931104, 2022
122022
The evolution of acquired resistance to BRAFV600E kinase inhibitor is sustained by IGF1-driven tumor vascular remodeling
G Xu, Y Luo, W Wu, X Liu, X Yu, Y Bao, X He, J Yu, Y Li, J Yang, R Zhang, ...
Journal of Investigative Dermatology 142 (2), 445-458, 2022
112022
A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosis
Q Lei, L Zhang, Y Xia, T Ye, F Yang, Y Zhu, X Song, N Wang, Y Xu, X Liu, ...
RSC Advances 5 (52), 41341-41351, 2015
112015
Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
J Yu, X Wu, J Song, Y Zhao, H Li, M Luo, X Liu
Frontiers in Pharmacology 13, 928226, 2022
92022
Application of artificial intelligence to the public health education
X Wang, X He, J Wei, J Liu, Y Li, X Liu
Frontiers in public health 10, 1087174, 2023
72023
Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy
T Xu, Z Liu, L Huang, J Jing, X Liu
Frontiers in Immunology 13, 1057850, 2022
62022
The system can't perform the operation now. Try again later.
Articles 1–20